-- Auro Laboratories (BOM:530233) received an Attestation of Inspection from the European Directorate for the Quality of Medicines and Healthcare (EDQM) for its Metformin Hydrochloride CEP dossier, according to a Tuesday filing on BSE.
Shares of the company rose nearly 4% in Wednesdays trade.
The certification confirms compliance with Good Manufacturing Practice (GMP) requirements under EU rules for its MIDC Tarapur facility, the filing said.